A detailed history of Canton Hathaway, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Canton Hathaway, LLC holds 11,554 shares of PFE stock, worth $291,507. This represents 0.08% of its overall portfolio holdings.

Number of Shares
11,554
Previous 11,554 -0.0%
Holding current value
$291,507
Previous $323,000 3.41%
% of portfolio
0.08%
Previous 0.09%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

BUY
$25.26 - $29.6 $25,260 - $29,600
1,000 Added 9.48%
11,554 $323,000
Q1 2024

May 13, 2024

BUY
$25.89 - $29.73 $77,670 - $89,190
3,000 Added 39.71%
10,554 $293,000
Q4 2023

Jan 30, 2024

BUY
$26.13 - $33.94 $130,650 - $169,700
5,000 Added 195.77%
7,554 $217,000
Q3 2023

Oct 11, 2023

BUY
$32.09 - $37.51 $18,708 - $21,868
583 Added 29.58%
2,554 $85,000
Q4 2022

Jan 19, 2023

BUY
$41.75 - $54.5 $1,670 - $2,180
40 Added 2.07%
1,971 $101,000
Q3 2022

Oct 17, 2022

SELL
$43.76 - $53.42 $37,196 - $45,407
-850 Reduced 30.56%
1,931 $85,000
Q3 2021

Oct 14, 2021

BUY
$39.25 - $50.42 $37,091 - $47,646
945 Added 51.47%
2,781 $120,000
Q2 2021

Jul 08, 2021

BUY
$35.91 - $40.68 $3,088 - $3,498
86 Added 4.91%
1,836 $72,000
Q1 2021

Apr 14, 2021

BUY
$33.49 - $37.77 $24,447 - $27,572
730 Added 71.57%
1,750 $63,000
Q4 2020

Feb 03, 2021

BUY
$33.47 - $42.56 $5,689 - $7,235
170 Added 20.0%
1,020 $38,000
Q1 2020

May 06, 2020

SELL
$27.03 - $38.62 $13,515 - $19,310
-500 Reduced 37.04%
850 $28,000
Q3 2019

Oct 11, 2019

SELL
$32.49 - $42.13 $25,504 - $33,072
-785 Reduced 36.77%
1,350 $49,000
Q2 2019

Jul 15, 2019

BUY
$36.98 - $41.52 $29,029 - $32,593
785 Added 58.15%
2,135 $92,000
Q3 2018

Oct 12, 2018

BUY
$34.47 - $41.81 $46,534 - $56,443
1,350 New
1,350 $59,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $142B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Canton Hathaway, LLC Portfolio

Follow Canton Hathaway, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canton Hathaway, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Canton Hathaway, LLC with notifications on news.